A COMPARISON OF PLASMA NITRITE, NTTRATE AND ASYMMETRIC DIMETHYL ARGININE LEVELS MAJOR DEPRESSION PATIENTS BEFORE AND AFTER ESCITALOPRAM TREATMENT

被引:0
作者
Hisarvant, Arzu [1 ]
Ataoglu, Ahmet [2 ]
Ozcetin, Adnan [2 ]
Kilic, Osman [3 ]
Olmez, Safiye Bahar [2 ]
KudubanHalil, Ali Kemal [4 ]
机构
[1] Halil Sivgin Cubuk Devlet Hastanesi, Ankara, Turkey
[2] Duzce Univ, Tip Fak Ruh Sagligi Hastaliklari Anabilim Dali, Duzce, Turkey
[3] Izmir Menemen Devlet Hastanesi, Izmir, Turkey
[4] Hatay Dortyol Devlet Hastanesi, Antakya, Turkey
来源
NOBEL MEDICUS | 2018年 / 14卷 / 01期
关键词
Depressive disorder; nitrat; nitrite; asymmetric dimetilaiginin; escitalopram;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Asymmetric dimethyl arginine (ADMA) f unction, which is an intracellular repressor of nitric oxide (NO) and NO, examined and revealed in many mental disorders. In this study, we compared the simultaneous levels of plasma nitrite (NO), nitrate (NO3) and ADMA before and after escitalopram treatment at Major Depression Disorder (MDD) patients and healthy controls. Material and Method: 40 patients with MDD according to DSM-IV-IR and 40 heathy controls was included in this study. The Montgomery-Asberg Depression Rating Scale was used to determine the severity of illness. Plasma NO2, NO3 and ADMA levels were measured in the MDD and the control groups. Results: Pretreatment plasma NO2, NO3 and ADMA levels in MDD group were significantly lower (but ADMA levels were higher) than in the control group. After the treatment NO levels of MDD group were close to control group. ADMA levels were statistically lower than the control group. Conclusion: Our study can contribute to the understanding of the role of NO and ADMA and relationship between complicated neurotransmitter systems at MDD etiopathogenesis.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 37 条
[1]   EVIDENCE THAT NITRIC-OXIDE MODULATES DRINKING BEHAVIOR [J].
CALAPAI, G ;
SQUADRITO, F ;
ALTAVILLA, D ;
ZINGARELLI, B ;
CAMPO, GM ;
CILIA, M ;
CAPUTI, AP .
NEUROPHARMACOLOGY, 1992, 31 (08) :761-764
[2]  
Chapman D.P., 2008, PREVENTING CHRONIC D, V5, P1
[3]   Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder [J].
Chrapko, WE ;
Jurasz, P ;
Radomski, MW ;
Lara, N ;
Archer, SL ;
Le Mellédo, JM .
BIOLOGICAL PSYCHIATRY, 2004, 56 (02) :129-134
[4]   Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients [J].
Chrapko, Wendy ;
Jurasz, Paul ;
Radomski, Marek W. ;
Archer, Stephen L. ;
Newman, Stephen C. ;
Baker, Glen ;
Lara, Nathalie ;
Le Mellédo, Jean-Michel .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (06) :1286-1293
[5]   Asymmetrical dimethylarginine - The Uber marker? [J].
Cooke, JP .
CIRCULATION, 2004, 109 (15) :1813-1818
[6]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[7]  
Datta S, 1997, SYNAPSE, V27, P69, DOI 10.1002/(SICI)1098-2396(199709)27:1<69::AID-SYN7>3.3.CO
[8]  
2-6
[9]  
Dhir A., 2016, CURRENT ENZYME INHIB, V12, P40
[10]   Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat [J].
Gholami, A ;
Haeri-Rohani, A ;
Sahraie, H ;
Zarrindast, MR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (03) :269-277